218 related articles for article (PubMed ID: 15704204)
1. Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome.
Awaad Y; Michon AM; Minarik S
Mov Disord; 2005 Jun; 20(6):714-8. PubMed ID: 15704204
[TBL] [Abstract][Full Text] [Related]
2. An open-label, prospective study of levetiracetam in children and adolescents with Tourette syndrome.
Fernández-Jaén A; Fernández-Mayoralas DM; Muñoz-Jareño N; Calleja-Pérez B
Eur J Paediatr Neurol; 2009 Nov; 13(6):541-5. PubMed ID: 19211282
[TBL] [Abstract][Full Text] [Related]
3. A double blind randomized placebo control trial of levetiracetam in Tourette syndrome.
Smith-Hicks CL; Bridges DD; Paynter NP; Singer HS
Mov Disord; 2007 Sep; 22(12):1764-70. PubMed ID: 17566124
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome.
Hedderick EF; Morris CM; Singer HS
Pediatr Neurol; 2009 Jun; 40(6):420-5. PubMed ID: 19433274
[TBL] [Abstract][Full Text] [Related]
5. Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.
Wasserman S; Iyengar R; Chaplin WF; Watner D; Waldoks SE; Anagnostou E; Soorya L; Hollander E
Int Clin Psychopharmacol; 2006 Nov; 21(6):363-7. PubMed ID: 17012983
[TBL] [Abstract][Full Text] [Related]
6. Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open-label study.
Cubo E; Fernández Jaén A; Moreno C; Anaya B; González M; Kompoliti K
Clin Ther; 2008 Jan; 30(1):182-9. PubMed ID: 18343255
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.
Müller-Vahl KR; Schneider U; Koblenz A; Jöbges M; Kolbe H; Daldrup T; Emrich HM
Pharmacopsychiatry; 2002 Mar; 35(2):57-61. PubMed ID: 11951146
[TBL] [Abstract][Full Text] [Related]
9. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
[TBL] [Abstract][Full Text] [Related]
10. Chronic tics and Tourette syndrome in patients with obsessive-compulsive disorder.
Diniz JB; Rosario-Campos MC; Hounie AG; Curi M; Shavitt RG; Lopes AC; Miguel EC
J Psychiatr Res; 2006 Sep; 40(6):487-93. PubMed ID: 16289552
[TBL] [Abstract][Full Text] [Related]
11. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
[TBL] [Abstract][Full Text] [Related]
12. Levetiracetam in the treatment of antipsychotics-resistant Tourette syndrome.
Oulis P; Karapoulios E; Masdrakis VG; Kouzoupis AV; Karakatsanis NA; Papageorgiou C; Papadimitriou GN; Soldatos CR
World J Biol Psychiatry; 2008; 9(1):76-7. PubMed ID: 17853302
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and emotional problems in adolescents with Tourette syndrome.
Chang HL; Liang HY; Wang HS; Li CS; Ko NC; Hsu YP
Chang Gung Med J; 2008; 31(2):145-52. PubMed ID: 18567414
[TBL] [Abstract][Full Text] [Related]
14. Rapid dosage titration of levetiracetam in children.
Vaisleib II; Neft RA
Pharmacotherapy; 2008 Mar; 28(3):393-6. PubMed ID: 18294118
[TBL] [Abstract][Full Text] [Related]
15. 1-Hz low frequency repetitive transcranial magnetic stimulation in children with Tourette's syndrome.
Kwon HJ; Lim WS; Lim MH; Lee SJ; Hyun JK; Chae JH; Paik KC
Neurosci Lett; 2011 Mar; 492(1):1-4. PubMed ID: 21256925
[TBL] [Abstract][Full Text] [Related]
16. Antiepileptic drugs and Tourette syndrome.
Cavanna AE; Nani A
Int Rev Neurobiol; 2013; 112():373-89. PubMed ID: 24295627
[TBL] [Abstract][Full Text] [Related]
17. Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy.
Specchio N; Boero G; Michelucci R; Gambardella A; Giallonardo AT; Fattouch J; Di Bonaventura C; de Palo A; Ladogana M; Lamberti P; Vigevano F; La Neve A; Specchio LM
Epilepsia; 2008 Apr; 49(4):663-9. PubMed ID: 18266754
[TBL] [Abstract][Full Text] [Related]
18. Treatment of phonic tics in patients with Tourette's syndrome using botulinum toxin type A.
Porta M; Maggioni G; Ottaviani F; Schindler A
Neurol Sci; 2004 Feb; 24(6):420-3. PubMed ID: 14767691
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric disorders and behavioral problems in children and adolescents with Tourette syndrome.
Ghanizadeh A; Mosallaei S
Brain Dev; 2009 Jan; 31(1):15-9. PubMed ID: 18558469
[TBL] [Abstract][Full Text] [Related]
20. Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy.
Specchio LM; Gambardella A; Giallonardo AT; Michelucci R; Specchio N; Boero G; La Neve A
Epilepsy Res; 2006 Sep; 71(1):32-9. PubMed ID: 16814521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
